Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place
They recomended a buy 10-23-07:
http://www.americanbulls.com/StockPage.asp?CompanyTicker=PLRS&MarketTicker=OTC&TYP=S